Guy Wendy 4

What Happened
Guy Wendy, Chief Administrative Officer of Processa Pharmaceuticals (PCSA), made an open-market purchase of 1,748 shares on April 30, 2026. The shares were acquired at $2.69 per share for a total cash outlay of $4,702. This was a straight purchase (transaction code P), which is generally a more informative signal than routine sales.

Key Details

• Transaction date: 2026-04-30
• Transaction type: Open-market purchase (Code P)
• Price per share: $2.69
• Shares acquired: 1,748
• Total value: $4,702
• Shares owned after the transaction: Not specified in the filing
• Filing date: 2026-05-01 (filed one day after the trade; appears timely)
• Notable footnotes: None listed (no 10b5-1 plan, tax withholding, or other special conditions disclosed)

Context
This is a small, outright purchase via the open market. Purchases by insiders can be viewed as a modest bullish signal, but the trade size here ($4.7k) is limited — useful to note but not conclusive on its own. The filing appears timely and contains no additional qualifiers.